NASDAQ:ALXO

Alx Oncology Holdings Stock Forecast

etoro logo Buy ALXO
*Your capital is at risk
$1.97
-0.155 (-7.29%)
At Close: Jul 13, 2026
AI Analysis AI Analysis of ALXO AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ALXO to Watchlist?
Some Reasons Why To Add ALXO:
  • +320.2% price growth over the last year
  • +71.3% YTD performance
  • Bullish trend confirmed on both short and long timeframes
PDF

ALX Oncology Holdings Inc. stock price fell more than -7.29% Monday closing at $1.97
(Updated on Jul 13, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jul 01, 2026 Loss -4.37%

The ALX Oncology Holdings Inc. stock price fell by -7.29% on the last day (Monday, 13th Jul 2026) from $2.13 to $1.97. During the last trading day the stock fluctuated 9.54% from a day low at $1.94 to a day high of $2.13. The price has been going up and down for this period, and there has been a -3.43% loss for the last 2 weeks. Volume has increased on the last day by 434 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $2.39 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.67% during the next 3 months and, with a 90% probability hold a price between $1.60 and $2.63 at the end of this 3-month period.

ALXO Signals & Forecast

The ALX Oncology Holdings Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $2.16. On a fall, the stock will find some support from the long-term average at approximately $1.83. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -16.53%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for ALX Oncology Holdings Inc. stock

ALX Oncology Holdings Inc. finds support from accumulated volume at $1.96 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.185 between high and low, or 9.54%. For the last week, the stock has had daily average volatility of 10.19%.

Our recommended stop-loss: $1.88 (-4.78%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (ALXO) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect ALX Oncology Holdings Inc. to open at $2.01, and during the day (based on 14 day Average True Range), to move between $1.88 and $2.06, which gives a possible trading interval of +/-$0.175 (+/-9.30%) up or down from last closing price. If ALX Oncology Holdings Inc. takes out the full calculated possible swing range there will be an estimated 9.30% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.96 (0.51%) than the resistance at $2.04 (3.55%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is ALX Oncology Holdings Inc. stock A Buy?

ALX Oncology Holdings Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.106 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $2.01 ( 2.12%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ALXO Performance

Trading levels for ALXO

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.20 11.51%
R2 2.13 7.92%
R1 2.08 5.70%
Price 1.97
S1 1.94 -1.47%
S2 1.90 -3.69%
S3 1.83 -7.28%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.20 11.68%
R2 2.07 5.08%
R1 2.04 3.55%
Price 1.97
S1 1.96 -0.508%
S2 1.70 -13.71%
S3 1.53 -22.34%

FAQ

What is the symbol for ALX Oncology Holdings Inc. Stock and on which exchange is it traded?
The symbol for ALX Oncology Holdings Inc. is ALXO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ALX Oncology Holdings Inc. Stock?
ALX Oncology Holdings Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

How to buy ALX Oncology Holdings Inc. Stock?
ALX Oncology Holdings Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ALX Oncology Holdings Inc. Stock.

What's the current price of ALX Oncology Holdings Inc. Stock?
As of the end of day on the Jul 13, 2026, the price of an ALX Oncology Holdings Inc. (ALXO) share was $1.97.

What is the 52-week high and low for ALX Oncology Holdings Inc. Stock?
The 52-week high for ALX Oncology Holdings Inc. Stock is $2.66 and the 52-week low is $0.450.

What is the market capitalization of ALX Oncology Holdings Inc. Stock?
As of the Jul 13, 2026, the market capitalization of ALX Oncology Holdings Inc. is 265.089M.

When is the next earnings date for ALX Oncology Holdings Inc.?
The upcoming earnings date for ALX Oncology Holdings Inc. is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT ALX ONCOLOGY HOLDINGS INC.
ALX Oncology Holdings
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hodgkin's lymphoma, as well as a range of solid tumor indications, including head and neck squamous cell c...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE